Irish drugs firm Amryt Pharma eyes Nasdaq share listing

Irish-based drug development company Amryt Pharma is seeking a share listing on New York’s Nasdaq stock market.

The biopharmaceutical company — which has its shares listed in Dublin and London — has submitted a draft registration statement for the Nasdaq listing to the US Securities and Exchange Commission (SEC).